ERBB2 and neoplasm: They found that CAR-M locally administered in HER2+ tumors simultaneously controlled the growth of contralateral HER2-negative tumors and prevented antigen-negative relapse upon an HER2-negative tumor rechallenge, indicating epitope spreading and the induction of long-term immune memory.